Multiple sclerosis treatments funding proposal

PHARMAC is seeking feedback on a funding proposal involving five treatments for multiple sclerosis, including two new treatments that are ...

Read more →

Call for patient input

CADTH has received notice of a pending submission from Vertex for Kalydeco (ivacaftor) for patients with cystic fibrosis. For information about ...

Read more →

Incruse Ellipta (umeclidinium) to be reimbursed in Australia for chronic obstructive pulmonary disease

GlaxoSmithKline (GSK) has welcomed the listing of Incruse Ellipta (umeclidinium) on the Australian Pharmaceutical Benefits Scheme (PBS) from December 1st ...

Read more →

Addition of therapeutic area as a filter

The addition of 'Therapeutic Area" as a filter will occur soon (more on this later). To ensure that the correct therapeutic ...

Read more →

Recommendations made by the PBAC - April 2015 PBAC special meeting

The recommendations made by the PBAC at its April 2015 special meeting are now available on the PBS website. ...

Read more →

Outcomes from the July 2013 PBAC meeting

[:content [\A \l \l \space \o \f \space \t \h \e \space \o \u \t \c \o \m \e \s \space \f \r \o \m \space \t \h \e \space \J \u \l \y \space \2 \0 \1 \3 \space \P \B \A \C \space \m \e \e \t \i \n \g \space \h \a \v \e \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \. \space \F \o \r \space \a \space \s \u \m \m \a \r \y \space \o \f " ..."]]
Read more →

Government congratulated on new Cabinet threshold

[:content [\T \h \e \space \a \n \n \o \u \n \c \e \m \e \n \t \space \b \y \space \t \h \e \space \A \b \b \o \t \t \space \G \o \v \e \r \n \m \e \n \t \space \t \o \d \a \y \space \t \h \a \t \space \i \t \space \h \a \s \space \c \o \n \f \i \r \m \e \d \space \a \space \n \e \w \space \t \h \r \e \s \h \o \l \d \space \f \o \r \space \C \a \b \i \n \e \t \space \a \p \p \r \o \v \a \l \space \o \f \space \n \e \w \space \m \e \d \i \c \i \n \e \s " ..."]]
Read more →

Merck CEO Ken Frazier on Keytruda and why Australians miss out on new drugs

The federal government's decision to list Keytruda, the breakthrough new cancer drug that rid businessman Ron Walker of terminal cancer, on the ...

Read more →

NICE recommends treatment for brain condition caused by liver failure

A drug to treat a potentially fatal brain condition caused by liver failure will be funded by the NHS following ...

Read more →

Only 3 in 20 new drugs approved in Germany in 2011 were an improvement, report says

[:content [\8 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \N \e \a \r \l \y \space \8 \5 \% \space \o \f \space \n \e \w \space \d \r \u \g \s \space \i \n \space \G \e \r \m \a \n \y \space \t \h \a \t \space \w \e \r \e \space \a \p \p \r \o \v \e \d \space \i \n \space \2 \0 \1 \1 \space \f \o \r \space \o \u \t \p \a \t \i \e \n \t \s \space \c \o \v \e \r \e \d \space \b \y \space \p \u \b \l \i \c " ..."]]
Read more →

PBS hospital medication chart

The Australian Commission on Safety and Quality in Health Care (ACSQHC, the Commission) is developing a national standardised medication chart for PBS ...

Read more →

'Early access' drugs scheme launched for severely ill

[:content [\1 \4 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \S \e \v \e \r \e \l \y \space \i \l \l \space \p \a \t \i \e \n \t \s \space \a \n \d \space \t \h \o \s \e \space \w \i \t \h \space \r \a \r \e \space \d \e \b \i \l \i \t \a \t \i \n \g \space \c \o \n \d \i \t \i \o \n \s \space \c \o \u \l \d \space \b \e \space \g \i \v \e \n \space \n \e \w \space \m \e \d \i \c \i \n \e \s \space \y \e \a \r \s \space \b \e \f \o \r \e \space \t \h \e \y " ..."]]
Read more →

Novartis' Xolair backed for NHS treatment of hives

Novarts’ Xolair (omalizumab) has been recommended for routine use by the National Health Service as an add-on treatment for patients ...

Read more →

Specialised Therapeutics Australia receives TGA approval for Abraxane in combination with gemcitabine for first-line treatment of metastatic pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in ...

Read more →

RFP – Supply of national vaccine storage and distribution services

PHARMAC invites proposals for the supply of national vaccine storage and distribution services to PHARMAC. ...

Read more →